Jerome J. Schentag

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Alan Forrest, David E. Nix, Charles H. Ballow et al. · Antimicrobial Agents and Chemotherapy · 1993 · 1.1K citations

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia

George Sakoulas, Pamela A. Moise-Broder, Jerome J. Schentag et al. · Journal of Clinical Microbiology · 2004 · 834 citations · Full text

Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

Pamela A. Moise-Broder, Alan Forrest, Mary C. Birmingham et al. · Clinical Pharmacokinetics · 2004 · 744 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +12

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Jennifer Thomas, Alan Forrest, Sujata M. Bhavnani et al. · Antimicrobial Agents and Chemotherapy · 1998 · 512 citations · Full text

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group

Mitchell P. Fink, David R. Snydman, Michael S. Niederman et al. · Antimicrobial Agents and Chemotherapy · 1994 · 460 citations · Full text